CI-988 (PD-134308) is a drug which acts as a cholecystokinin antagonist selective for the CCKB subtype. In animal studies it showed anxiolytic effects and potentiated the analgesic action of both morphine and endogenous opioid peptides as well as preventing the development of tolerance to opioids and reducing symptoms of withdrawal.
This page contains content from the copyrighted Wikipedia article "CI-988"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.